More importantly, our study showed that DAB2IP-deficient PCa cells have a greater sensitivity to Mps1 inhibitor than DAB2IP-proficient cells with a robust SAC (Fig. 4). The gene discussed is DAB2IP; the disease is posterior cortical atrophy.